Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Very Strong
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.0 - 0.0
Trade Value (12mth)
N/A
1 week
1.89%
1 month
1.89%
YTD
1.89%
1 year
0%
All time high
N/A
EPS 3 yr Growth
N/A
EBITDA Margin
N/A
Operating Cashflow
N/A
Free Cash Flow Return
N/A
ROIC
N/A
Interest Coverage
N/A
Quick Ratio
N/A
Shares on Issue (Fully Dilluted)
N/A
HALO Sector
Technology
Next Company Report Date
N/A
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
N/A
Short Sell (% of issue)
N/A
Date | Announcements |
---|---|
24 July 24 |
Study with Columbia University on Spinocerebellar Ataxias
×
Study with Columbia University on Spinocerebellar Ataxias |
12 July 24 |
BB1 Presentation - Bioshares Biotech Summit
×
BB1 Presentation - Bioshares Biotech Summit |
20 June 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
18 June 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
18 June 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
17 June 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
17 June 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
06 June 24 |
BlinkLab starts Clinical Study with Bates College
×
BlinkLab starts Clinical Study with Bates College |
05 June 24 |
BlinkLab signs Clinical Study Partnership with Erasmus MC
×
BlinkLab signs Clinical Study Partnership with Erasmus MC |
02 May 24 |
BlinkLab Partnership with Turning Pointe Autism Foundation
×
BlinkLab Partnership with Turning Pointe Autism Foundation |
02 May 24 |
Investor Presentation
×
Investor Presentation |
09 April 24 |
Becoming a substantial holder
×
Becoming a substantial holder |
09 April 24 |
Becoming a substantial holder
×
Becoming a substantial holder |
09 April 24 |
Becoming a substantial holder
×
Becoming a substantial holder |
09 April 24 |
Becoming a substantial holder
×
Becoming a substantial holder |
08 April 24 |
Initial Director's Interest Notice x4
×
Initial Director's Interest Notice x4 |
04 April 24 |
Investor Presentation
×
Investor Presentation |
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.